Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

NCT07166302 is registered in ClinicalTrials.gov with Masaryk University as lead sponsor.

NCT NCT07166302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07166302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Lead sponsor
Masaryk University
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2025
Completion date
December 31, 2026
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

direct acting anticoagulant adverse reaction, emg, mononeuropathies, needle injury, neuromuscular diseases (nmd), peripheral neuropathies, polyneuropathies